ID: ALA5280907

Max Phase: Preclinical

Molecular Formula: C19H23NO3S2

Molecular Weight: 377.53

Associated Items:

Representations

Canonical SMILES:  OCCSC(SCCO)c1ccc2c(c1)CCC(c1cccnc1)O2

Standard InChI:  InChI=1S/C19H23NO3S2/c21-8-10-24-19(25-11-9-22)15-4-6-17-14(12-15)3-5-18(23-17)16-2-1-7-20-13-16/h1-2,4,6-7,12-13,18-19,21-22H,3,5,8-11H2

Standard InChI Key:  OJCVELZBBAMXPZ-UHFFFAOYSA-N

Associated Targets(non-human)

L6 7924 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.53Molecular Weight (Monoisotopic): 377.1119AlogP: 3.60#Rotatable Bonds: 8
Polar Surface Area: 62.58Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.70CX LogP: 2.72CX LogD: 2.72
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: 0.22

References

1. Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A..  (2023)  Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators.,  87  [PMID:37167713] [10.1016/j.bmc.2023.117303]

Source